ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Order Full text via Infotrieve
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shahzeidi, S
Right arrow Articles by Laurent, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shahzeidi, S
Right arrow Articles by Laurent, G.
Eur Respir J 1991; 4: 845-852
Copyright © ERS Journals Ltd 1991


Original Articles

Oral N-acetylcysteine reduces bleomycin-induced collagen deposition in the lungs of mice

S Shahzeidi, B Sarnstrand, PK Jeffery, RJ McAnulty, and GJ Laurent

N-acetylcysteine (NAC) has been employed in the treatment of acute lung injury but its therapeutic value is as yet unproven. In the present study we examined the effect of both L- and D-forms of NAC as inhibitors of bleomycin-induced fibrosis in mice. We hypothesized that, because of the D-form is not metabolized, it may be more effective than the L-form in ameliorating lung injury and fibrosis. Both drugs were given daily in the drinking water at a dose of approximately 400 mg.kg-1 body weight commencing one week prior to a single intratracheal instillation of bleomycin at a dose of 6 mg.kg-1 body weight. Lung injury was assessed 35 days later by measuring total lung collagen content, lung wet weight and examination of tissues by light and electron microscopy. Total collagen content and lung wet weight of animals receiving bleomycin together with L-NAC were 2.90 +/- 0.03 mg and 0.23 +/- 0.01 g, respectively. The values for collagen content, but not wet weight, were significantly less (p less than 0.05) than those given for bleomycin alone (3.90 +/- 0.02 mg and 0.260 +/- 0.005 g, respectively), but greater than (p less than 0.05) controls (2.10 +/- 0.01 mg and 0.160 +/- 0.002 g, respectively). Values for collagen content and wet weight of animals given bleomycin together with D-NAC (3.10 +/- 0.02 mg and 0.21 +/- 0.01 mg, respectively) were both significantly greater than values for control animals but lower than animals given bleomycin alone.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
A. J. Marian, V. Senthil, S. N. Chen, and R. Lombardi
Antifibrotic Effects of Antioxidant N-Acetylcysteine in a Mouse Model of Human Hypertrophic Cardiomyopathy Mutation
J. Am. Coll. Cardiol., February 21, 2006; 47(4): 827 - 834.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. L. Rubio, M. C. Martin-Mosquero, M. Ortega, G. Peces-Barba, and N. Gonzalez-Mangado
Oral N-Acetylcysteine Attenuates Elastase-Induced Pulmonary Emphysema in Rats
Chest, April 1, 2004; 125(4): 1500 - 1506.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
M. Mata, A. Ruiz, M. Cerda, M. Martinez-Losa, J. Cortijo, F. Santangelo, A. Serrano-Mollar, A. Llombart-Bosch, and E.J. Morcillo
Oral N-acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats
Eur. Respir. J., December 1, 2003; 22(6): 900 - 905.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
A Serrano-Mollar, D Closa, J Cortijo, E J Morcillo, N Prats, M Gironella, J Panes, J Rosello-Catafau, and O Bulbena
P-selectin upregulation in bleomycin induced lung injury in rats: effect of N-acetyl-L-cysteine
Thorax, July 1, 2002; 57(7): 629 - 634.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
H.-D. WANG, M. YAMAYA, S. OKINAGA, Y.-X. JIA, M. KAMANAKA, H. TAKAHASHI, L.-Y. GUO, T. OHRUI, and H. SASAKI
Bilirubin Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats
Am. J. Respir. Crit. Care Med., February 1, 2002; 165(3): 406 - 411.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
J. Cortijo, M. Cerda-Nicolas, A. Serrano, G. Bioque, J.M. Estrela, F. Santangelo, A. Esteras, A. Llombart-Bosch, and E.J. Morcillo
Attenuation by oral N-acetylcysteine of bleomycin-induced lung injury in rats
Eur. Respir. J., June 1, 2001; 17(6): 1228 - 1235.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
T. Yehualaeshet, R. O'Connor, A. Begleiter, J. E. Murphy-Ullrich, R. Silverstein, and N. Khalil
A CD36 Synthetic Peptide Inhibits Bleomycin-Induced Pulmonary Inflammation and Connective Tissue Synthesis in the Rat
Am. J. Respir. Cell Mol. Biol., August 1, 2000; 23(2): 204 - 212.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
S.-I. HAGIWARA, Y. ISHII, and S. KITAMURA
Aerosolized Administration of N-Acetylcysteine Attenuates Lung Fibrosis Induced by Bleomycin in Mice
Am. J. Respir. Crit. Care Med., July 1, 2000; 162(1): 225 - 231.
[Abstract] [Full Text]


Home page
Hum Exp ToxicolHome page
J. Meulenbelt, L. van Bree, J.A.M.A. Dormans, and B. Sangster
No Beneficial Effect of N-acetylcysteine Treatment on Broncho-alveolar Lavage Fluid Variables in Acute Nitrogen Dioxide Intoxicated Rats
Human and Experimental Toxicology, January 1, 1994; 13(7): 472 - 477.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the European Respiratory Society.